FMC Corp chairman and CEO Pierre Brondeau acquires $1.94 million in stock

PHILADELPHIA— FMC Corp (NYSE:FMC) Chairman and CEO Pierre R. Brondeau has recently acquired a significant amount of the company’s common stock, according to a filing with the Securities and Exchange Commission. On March 4, Brondeau purchased 54,000 shares at a weighted average price of $35.8972 per share. This transaction amounts to a total value of approximately $1.94 million. The purchase comes as FMC’s stock trades near its 52-week low of $33.80, having declined over 42% in the past six months. According to InvestingPro analysis, the stock currently appears undervalued based on its Fair Value assessment.

The purchase increases Brondeau’s direct ownership to 298,439 shares of FMC Corp. The shares were acquired at prices ranging from $35.83 to $35.95, as detailed in the filing. This move underscores Brondeau’s continued confidence in the company’s prospects, which currently offers a notable 6.5% dividend yield and has maintained dividend payments for 19 consecutive years.

FMC Corp, headquartered in Philadelphia, is a leading player in the chemicals and allied products industry. The company, with a market capitalization of $4.6 billion and a P/E ratio of 13.5, has remained profitable over the last twelve months despite challenging market conditions. InvestingPro subscribers can access 8 additional key insights and a comprehensive Pro Research Report about FMC’s current market position and future prospects.

In other recent news, FMC Corporation reported a mixed financial outlook following its latest earnings report. The company exceeded consensus expectations for the fourth quarter earnings per share by $0.19, yet its forecast for 2025 fell short, with anticipated earnings per share between $3.26 and $3.70, compared to the projected $4.36. FMC Corp. estimates its 2025 sales to be between $4.15 billion and $4.35 billion, with earnings before interest, taxes, depreciation, and amortization (EBITDA) projected to range from $870 million to $950 million. Looking ahead to 2027, the company expects sales to reach $5.2 billion and EBITDA to climb to $1.2 billion. In response to these developments, Jefferies adjusted its price target for FMC Corp. to $49.00, maintaining a Buy rating, while Redburn-Atlantic downgraded the stock to Neutral with a $49.00 price target. Meanwhile, KeyBanc Capital Markets reduced its price target from $55.00 to $51.00 but retained an Overweight rating, citing challenges related to patent expirations. Additionally, FMC Corp. extended its $2.0 billion revolving credit facility to June 2028, enhancing its financial flexibility. These updates reflect the company’s strategic initiatives and the analyst firms’ varied perspectives on its future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.